Page last updated: 2024-10-25

deferoxamine and Autosomal Chromosome Disorders

deferoxamine has been researched along with Autosomal Chromosome Disorders in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambruso, DR1
Mahony, BS1
Githens, JH1
Rhoades, ED1
Saddi, R1
Feingold, J1

Other Studies

2 other studies available for deferoxamine and Autosomal Chromosome Disorders

ArticleYear
Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
    The American journal of pediatric hematology/oncology, 1982,Summer, Volume: 4, Issue:2

    Topics: Administration, Oral; Anemia, Aplastic; Ascorbic Acid; Blood Transfusion; Child; Chromosome Aberrati

1982
Idiopathic haemochromatosis: an autosomal recessive disease.
    Clinical genetics, 1974, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Chromosome Aberrations; Chromosome Disorders; Deferoxamine; Female;

1974